https://blog.google/technology/ai/bard-google-ai-search-updates/
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation For ARCT-810, mRNA Therapeutic Candidate For Ornithine Transcarbamylase Deficiency
Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines